The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will host a webinar on June 29th, 2021, at 11:00 AM EDT. Presenters include Senior Director of AstraZeneca R&D China Dr. Yan Xiao and Director of RWE & Data Science, Innovation & Partnerships at Novartis Dr. Sara Bruce Wirta. Speakers will discuss how real world data (RWD) can be used to improve market access for oncology drugs and outcomes in China.
“The potential to improve cancer care in China is clear, the journey to that destination is not. Here, we bring together a group of experienced RWE leaders, thinkers, and “doers” for an interactive, friendly, and informative discussion about the unique attributes of oncology care in China: diverse patient journeys, integration with traditional medicines, immature EHR integration across institutions, and the rapidly evolving regulatory and reimbursement environment.” Register here.
(Source: ISPOR, 2021)
